The World Health Organisation (WHO) estimates that around 17.7 million fatalities in India are attributable to stroke and ischemic heart disease. Many young people are included in this total. Since the COVID-19 pandemic may induce a heart attack, it is a trigger. World Heart Day is celebrated annually on September 29 in honor of the WHF.
By allowing for earlier diagnosis and treatment, these technological advances are helping save the lives of severely sick people. Explore the emerging technologies that have the potential to revolutionize the field of cardiac care.
Treatment for Heart
A heart attack occurs when a blood clot closes off one of the coronary arteries supplying blood to the heart. Part of the heart that loses oxygen from a blockage dies and eventually scars over.
“Our previous lab studies and human clinical trials have shown promise in treating heart failure using cardiac stem cell infusions,” stated Marbán. It turns out that these specialized stem cells may be able to cure cardiac issues related to aging.
Patch Of Skin Used As A Counterstroke
The odds of survival after a stroke may be increased by using a simple skin patch. Impressive, but real. A skin patch that may be put in an ambulance to a patient suspected of having a stroke is currently in development by researchers at the University of Nottingham. The chemical glyceryl trinitrate, delivered through this patch, may dilate blood vessels and reduce blood pressure, reducing the risk of stroke.
Within an hour after stroke onset, therapy might drastically improve outcomes. Time spent treating patients in ambulances before they reach the hospital may be better spent elsewhere. If this patch proves safe, researchers hope paramedics use it in the field or areas without access to standard medical care.
The Heartmate 3 is an innovative therapy for heart failure that aids blood pumping from the heart’s left ventricle. Heartmate 3 therapy aims to enhance patients’ quality of life and lengthen their lifespan. The battery-operated gadget may be surgically implanted. It improves cardiac function and decreases the number of patients hospitalized with heart failure. Those who are not suitable candidates for a heart transplant or waiting for one might consider this alternative treatment.
Artificial Heart Monitors
Patients with heart failure often have cardiac rhythm disturbances. It might be overly sluggish, too rapid, or erratic. We use ECG recordings to identify the source of a cardiac rhythm disturbance. Electrocardiograms only provide a snapshot in time. What if a doctor has to monitor rhythm for a while to get a complete picture of the patient’s health?
Implantable heart monitors are currently under development. These small, implantable devices are used to monitor and record a patient’s cardiac activity.
Cholesterol-Fighting Nanomaterials
Researchers are busy developing new nanomaterials. These nanoparticles may transport cholesterol-lowering medications directly to the organs that need them. Nanomaterials are very stable despite their microscopic dimensions. After the drugs have been transported to their destinations, they biodegrade independently.
Printing in Three Dimensions
Already, 3-D printed anatomy using CT datasets is being utilised as a teaching tool in several medical institutions throughout the United States. Using this technology, Cardiologist in Mansarovar Jaipur have planned very intricate heart operations. Damaged structures like heart valves may be replaced with a custom-made component using 3-D printing technology. According to a recent Diagnostic and Interventional Cardiology report, virtual device implantations using 3D computer software are becoming increasingly popular to improve patient selection, lessen the likelihood of postoperative complications, and speed up the creation of trans-catheter devices and procedures.
Mitraclip
Mitraclip therapy is a potential approach for treating heart failure. Mitraclip is an intracardiac device designed to improve cardiac output. People with moderate to severe heart failure who have not responded to medicine or lifestyle modifications may benefit from this procedure.
Patients with heart failure have reported increased quality of life and exercise tolerance after receiving mitraclip treatment. Hospitalization and mortality due to heart failure may be decreased as a result.
The Use Of Machine Learning And Artificial Intelligence In The Analysis Of Cardiac Function
Thanks to technological progress, computers can now swiftly and correctly process massive volumes of data. By enabling the identification of particular patterns in patient data, this learning enhances decision-making, accurate diagnosis, and treatment planning. Researchers and clinicians in cardiovascular medicine are beginning to integrate AI into their daily work. Here are two case studies to further illustrate how physicians benefit from AI.
Saving precious time, computers can now study CT scans of patients suspected of having strokes and provide an accurate diagnosis.
Keeping your heart healthy – Any irregularity in the heart pump, which, if unchecked, might lead to heart failure, can be detected by applying AI to ECGs.
Almost 40,000 people in the United States annually need a heart transplant. However, only around 2,200 hearts from living donors are available each year. With this gadget, the patient will experience pulseless blood flow since it consists of flexible parts and has no valves.
Cohn and his colleagues placed the gadget on a guy suffering from numerous organ failures. The device functioned flawlessly, allowing the guy to survive for another six weeks despite his lung and liver loss. The patient’s loved ones eventually asked Cohn to turn off the machine so their loved one could pass away.
Because of its ability to provide immediate responses to changes in cardiac output and intravascular volume status, personalized volume management systems (PVM) hold great promise for improving the treatment of heart failure. PVM systems include sensors for real-time monitoring of hemodynamic parameters and algorithms to determine patient-specific fluid status goals. Clinicians may use the systems’ recommendations to enhance cardiac output and lessen congestion by optimizing fluid status.
Clinical results for patients with heart failure have improved thanks to PVM devices, which have decreased hospitalization and death rates. Patients’ quality of life and exercise tolerance both increase with PVM-guided treatment.
Conclusion
Heart specialist in Jaipur now have more effective medicines to prevent the body’s immune system from rejecting a heart transplant. There is now more good news for those waiting for an organ transplant: we know that hearts donated by patients with hepatitis C are a safe choice.
